Post-traumatic osteoarthritis development is not modified by postnatal chondrocyte deletion of Ccn2

ABSTRACT CCN2 is a matricellular protein involved in several crucial biological processes. In particular, CCN2 is involved in cartilage development and in osteoarthritis. Ccn2 null mice exhibit a range of skeletal dysmorphisms, highlighting its importance in regulating matrix formation during development; however, its role in adult cartilage remains unclear. The aim of this study was to determine the role of CCN2 in postnatal chondrocytes in models of post-traumatic osteoarthritis (PTOA). Ccn2 deletion was induced in articular chondrocytes of male transgenic mice at 8 weeks of age. PTOA was induced in knees either surgically or non-invasively by repetitive mechanical loading at 10 weeks of age. Knee joints were harvested, scanned with micro-computed tomography and processed for histology. Sections were stained with Toluidine Blue and scored using the Osteoarthritis Research Society International (OARSI) grading system. In the non-invasive model, cartilage lesions were present in the lateral femur, but no significant differences were observed between wild-type (WT) and Ccn2 knockout (KO) mice 6 weeks post-loading. In the surgical model, severe cartilage degeneration was observed in the medial compartments, but no significant differences were observed between WT and Ccn2 KO mice at 2, 4 and 8 weeks post-surgery. We conclude that Ccn2 deletion in chondrocytes does not modify the development of PTOA in mice, suggesting that chondrocyte expression of CCN2 in adults is not a crucial factor in protecting cartilage from the degeneration associated with PTOA. This article has an associated First Person interview with the first author of the paper. Summary: Postnatal deletion of Ccn2 in chondrocytes does not affect the development of post-traumatic osteoarthritis in mice.

[1]  Soichiro Ibaragi,et al.  Expression and Role of IL-1β Signaling in Chondrocytes Associated with Retinoid Signaling during Fracture Healing , 2020, International journal of molecular sciences.

[2]  A. Didangelos,et al.  Connective tissue growth factor contributes to joint homeostasis and osteoarthritis severity by controlling the matrix sequestration and activation of latent TGFβ , 2018, Annals of the rheumatic diseases.

[3]  B. Perbal The concept of the CCN protein family revisited: a centralized coordination network , 2018, Journal of Cell Communication and Signaling.

[4]  B. Perbal Once upon a time ...A special issue for the 10th anniversary of the Journal of Cell Communication and Signaling , 2018, Journal of Cell Communication and Signaling.

[5]  P. Clegg,et al.  Differential tissue specific, temporal and spatial expression patterns of the Aggrecan gene is modulated by independent enhancer elements , 2018, Scientific Reports.

[6]  M. Brown,et al.  Serum connective tissue growth factor is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis , 2017, Arthritis Research & Therapy.

[7]  M. Young,et al.  WISP1/CCN4 aggravates cartilage degeneration in experimental osteoarthritis. , 2017, Osteoarthritis and cartilage.

[8]  M. Takigawa,et al.  CCN4/WISP-1 positively regulates chondrogenesis by controlling TGF-β3 function. , 2016, Bone.

[9]  M. Takigawa,et al.  Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions. , 2015, Clinical science.

[10]  J. Saklatvala,et al.  Generation of a mouse line harboring a bi‐transgene expressing luciferase and tamoxifen‐activatable creERT2 recombinase in cartilage , 2014, Genesis.

[11]  F. Barry,et al.  Mesenchymal stem cells in joint disease and repair , 2013, Nature Reviews Rheumatology.

[12]  T. Yamashiro,et al.  CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Has Anti-Aging Effects That Protect Articular Cartilage from Age-Related Degenerative Changes , 2013, PloS one.

[13]  T. Yamashiro,et al.  Cartilage–Specific Over-Expression of CCN Family Member 2/Connective Tissue Growth Factor (CCN2/CTGF) Stimulates Insulin-Like Growth Factor Expression and Bone Growth , 2013, PloS one.

[14]  S. Honsawek,et al.  Plasma and synovial fluid connective tissue growth factor levels are correlated with disease severity in patients with knee osteoarthritis , 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[15]  C. Little,et al.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. , 2010, Osteoarthritis and cartilage.

[16]  M. Takigawa,et al.  CCN family 2/connective tissue growth factor (CCN2/CTGF) stimulates proliferation and differentiation of auricular chondrocytes. , 2008, Osteoarthritis and cartilage.

[17]  V. Lefebvre,et al.  L-Sox5 and Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-Upstream Enhancer , 2008, Molecular and Cellular Biology.

[18]  M. Barbe,et al.  Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF‐β1 to induce mesenchymal cell condensation , 2007, Journal of cellular physiology.

[19]  S. Kondo,et al.  Roles of PKC, PI3K and JNK in multiple transduction of CCN2/CTGF signals in chondrocytes. , 2006, Bone.

[20]  F. Mooren,et al.  Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. , 2006, Arthritis and rheumatism.

[21]  Kozo Nakamura,et al.  Osteoarthritis development in novel experimental mouse models induced by knee joint instability. , 2005, Osteoarthritis and cartilage.

[22]  Changshan Wu,et al.  Retinoid Signaling Regulates CTGF Expression in Hypertrophic Chondrocytes With Differential Involvement of MAP Kinases , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  H. Inoue,et al.  Expression and localization of connective tissue growth factor (CTGF/Hcs24/CCN2) in osteoarthritic cartilage. , 2004, Osteoarthritis and cartilage.

[24]  Y. Tabata,et al.  Regeneration of Defects in Articular Cartilage in Rat Knee Joints by CCN2 (Connective Tissue Growth Factor) , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  B. Perbal CCN proteins: multifunctional signalling regulators , 2004, The Lancet.

[26]  B. Yoon,et al.  Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development , 2003, Development.

[27]  M. Takigawa,et al.  Role of CTGF/HCS24/ecogenin in skeletal growth control , 2003, Journal of cellular physiology.

[28]  H. Inoue,et al.  Expression of connective tissue growth factor/hypertrophic chondrocyte-specific gene product 24 (CTGF/Hcs24) during fracture healing. , 2002, Bone.

[29]  S. Kondo,et al.  CTGF/Hcs24, a hypertrophic chondrocyte‐specific gene product, stimulates proliferation and differentiation, but not hypertrophy of cultured articular chondrocytes , 2002, Journal of cellular physiology.

[30]  H. Yatani,et al.  Regulatory mechanism of human connective tissue growth factor (CTGF/Hcs24) gene expression in a human chondrocytic cell line, HCS-2/8. , 2001, Journal of biochemistry.

[31]  S. Yoshida,et al.  Retinoic Receptor Signaling Regulates Hypertrophic Chondrocyte-specific Gene Expression , 2018, In Vivo.

[32]  A. Pitsillides,et al.  Characterizing a novel and adjustable noninvasive murine joint loading model. , 2011, Arthritis and rheumatism.

[33]  M. Takigawa,et al.  Effects of CTGF/Hcs24, a Product of a Hypertrophic Chondrocyte-Specific Gene, on the Proliferation and Differentiation of Chondrocytes in Culture1. , 2000, Endocrinology.